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to its abolition during intravenous tocainide administra- 
tion. It seems likely that acceleration of VT rate was 
induced by tocainide, since in both of our patients their 
episodic VT had been at constant frequency during obser- 
vation for 1 month. Although both of these patients had 
severe underlying heart disease with chronic potentially 
life-threatening recurrent VT, VF occurred only once in 
each individual and in each instance in close proximity to 
initiation of tocainide therapy. Furthermore, VF has not 
reoccurred since tocainide was discontinued. There were 
no apparent metabolic or electrolyte abnormalities which 
might have explained their worsening of ventricular 
tachyarrhythmias during tocainide. Other antiarrhythmic 
drugs had been discontinued sufficiently prior to VF to 
make such change in therapy an important factor. Serum 
digoxin concentrations were at levels unlikely to be asso- 
ciated with toxic arrhythmias. While a potential interac- 
tion between tocainide and digoxin might have resulted in 
VF, such an event has not been observed with lidocaine, a 
drug with similar structure and electrophysiologic effects 
as tocainide. While it ;S not possible to exclude the causal 
relation of their severe underlying cardiac disease pro- 
cesses or disturbed pharmacokinetics due to related organ 
system dysfunction, it is not unreasonable to suspect that 
tocainide was responsible for initiation of VF in these two 
patients. 
Unfortunately, tocainide blood levels were not available 
in both patients. Tocainide is principally removed (45%) 
by excretion in the urine in unchanged form and 23% is 
metabolized by carboxylation in the liver. Since our first 
patient had severe congestive heart failure, impaired 
excretion might have resulted in toxic blood levels. How- 
ever, our second patient had normal renal and hepatic 
function. Based on previous experience with the pharma- 
cokinetics of this highly bioavailable oral drug,‘, 6 it is 
quite unlikely that our second patient had toxic serum 
levels. Furthermore, signs and symptoms of CNS or 
gastrointestinal toxicity were absent in both patients, and 
these side effects usually occur with high tocainide blood 
levels.‘,6 Based on these two untoward experiences, we 
now believe that it is prudent to initiate tocainide therapy 
in a monitored hospital setting. The drug has proved 
useful in patients with refractory ventricular tachyarr- 
hythmias and we continue to find tocainide salutary in 
such patients. 
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The occurrence of tricuspid atresia and Wolff-Parkinson- 
White syndrome in a single patient is rare, occurring in 
only one among 349 patients with tricuspid atresia 
included in three recently published reviews.‘-” Despite the 
reported uncommon coexistence of these two complex 
lesions, recent advances in their individual surgical man- 
agement as well as the hemodynamic deterioration which 
frequently accompanies paroxysmal supraventricular 
tachycardia (PSVT) prompted us to report the successful 
division of a right-sided posterior bypass tract and the 
creation of a valveless right atria1 to right ventricular 
conduit in an l&year-old girl with tricuspid atresia and 
the pre-excitation syndrome. 
At 3 months of age the patient demonstrated during 
cardiac catheterization tricuspid atresia with normally 
related great arteries; a right Blalock-Taussig anastomosis 
was performed 2 years later. At 5 years of age suspected 
anomalous atrioventricular conduction without PSVT 
was observed transiently on her electrocardiogram (Fig. 
l), followed by her first episode of PSVT at age 12 years. 
Six years later because of increasing polycythemia, exer- 
cise intolerance, and recurrent symptomatic PSVT, the 
patient underwent cardiac eatheterization and electro- 
physiologic study. Pulmonary arterial pressure was 22/12 
mm Hg. Electrophysiologic study (Figs. 2 and 3) demon- 
strated a right-sided bypass tract supporting the tachycar- 
dia retrogradely, with an antegrade effective refractory 
period of greater than 450 msec. Following these studies, 
atria1 and ventricular epicardial mapping (Fig. 4), division 
of the right-sided bypass tract, and a modified Fontan 
procedure4 were performed (Fig. 5). Following surgery 
both 24-hour Holter recording and postoperative pro- 
grammed atria1 extrastimuli delivered through transtho- 
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Fig. 1. Selected leads from the smface ECG prior to 
operation during &us rhythm and either normal atrio- 
ventricular conduction (left-hand column) or suspected 
anomalous (WPW) conduction (middle column). Leads 1 
and V, exhibit small delta waves and. a frontal plane QRS 
axis shift to a superior orientation. Postoperative selected 
leads (right-hand column) indicate a return to normal 
atrioventricular conduction. (Paper speed = 50 mm/set; 
10 mm defection equals 1 mV.) AV = atrioventricular; 
WPW = Wolff-Parkinson-White syndrome. 
racic temporary atria1 electrode wires failed to demon- 
strate tachycardia. One year following surgery the patient 
is improved without discernible cyanosis or tachyarr- 
hythmias. 
Despite the constraints imposed by the pathologic 
anatomy of tricuspid atresia, the electrophysiologic study 
proved to be important in establishing existence of an 
anomalous’ conduction pathway (Figs. 2, A and B), in 
.; 
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Fig. 2. Panel A shows tracings obtained at electrophysio- 
logic study during sinus rhythm and normal atrioventricu- 
lar conduction. Panel B shows tracings obtained at elec- 
trophysiologic study during sinus rhythm and anomalous 
atrioventricular conduction. Note the simultaneous acti- 
vation of the His bundle (H) and ventricle (QRS complex) 
indicated by the dotted vertical Zinc. All electrograms at 
cardiac catheterization and surgery were recorded 
through bipolar electrodes (1 to 10 mm apart) connected 
to an Electronics for Medicine V1205A amplifier. The 
signals were filtered through a band width of 30 to 250 Hz, 
monitored on an Electronics for Medicine (VRl2) 
switched-beamed oscilloscope and recorded on photo- 
graphic paper moving at 100 to 150 mm/set. 1, AVF, 
V, = standard surface ECG leads; A = atria1 electro- 
gram; HBE = His bundle tracing; RA = high right atria1 
tracing; H = His bundle electrogram; LA = left atria1 
tracing; V = ventricular electrograms. 
localizing the origin of the bypass tract on the right side 
(Fig. 3), and in defining the risk of rapid ventricular rates 
should atria1 flutter or fibrillation deve1op.j. 6 The demon- 
stration of ventricular excitation occurring simultaneous- 
ly with activation of the His bundle (Figs. 2,A and B) 
during periods of suspected anomalous conduction proved 
the presence of the bypass tract.% The minor shortening of 
the PR interval observed during suspected anomalous 
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Fig. 3. Tracings obtained at electrophysiologic study demonstrating the initiation of paroxysmal 
supraventricular tachycardia (PSVT) by a single atria1 premature stimulus (229 coupled (300 msec) to 
sinus rhythm. Note that during PSVT the right atrium is activated before the left atrium, indicating a 
right-side bypass tract. A smooth atrioventricular nodal conduction curve and absence of longitudinal 
dissociation militated against atrioventricular nodal reentry as the mechanism of this tachyarrhythmia. 
Note normal QRS morphology during the tachycardia, indicating the antegrade conduction during the 
tachycardia is through the normal atrioventricular pathway and retrograde conduction is through the 
bypass tract. 
Pig. 4; In Panel A, the ventricular epicardial activation sequence during antegrade anomalous (WPW) 
conduction is marked by IO msec intervals. The earliest activation of the ventricles occurred on the 
posterior diaphragmatic surface of the small right ventricle just to the right of the crux. Thus, the 
ventricular end of the anomalous pathway was identified. Anterior epicardial activation during anomalous 
conduction occurred earliest (30 to 40 msec) over the diminutive right ventricle, demonstrating that during 
anomalous conduction the ventricles were activated by both the normal and anomalous pathways, and 
that the surface~ECG with a superior frontal plane axis reflected fusion of these two activation wave 
fronts. Complete mapping of the posterior ventricular epicardium was not carried out to conserve 
operating time. Mercator projection of the heart is shown in Panel B. Atria1 epicardial mapping parallel to 
the right-sided atrioventricular groove was accomplished during Supraventricular tachycardia. This figure 
(Panel B) demonstrates a retrograde right atria1 epicardial activation sequence. The retrograde atria1 
activation time was measured from a reference ventricular electrogram to the atria1 electrogram recorded 
through the hand-held exploring electrode prode. Intervals are 10 msec, beginning at 150 msec. The 
earliest atria1 activation site during PSVT was located on the posterior right atrium slightly to the right of 
the earliest ventricular activation site obtained during anomalous antegrade conduction, thereby locating 
the atria1 end of the bypass tract and suggesting slight obliquity to its course. LA = left atrium; 
PA = pulmonary artery; RAA = right atria1 appendage; SVC = superior vena cava; LV = left ventricle; 
RA = right atrium; RV = right ventricle; WPW = Wolff-Parkinson-White syndrome. 
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Fig. 5. Diagram A shows the lordotic view of the heart (the view is as if one is looking at the heart from 
the diaphragm). The “Ebstein-like” pouch projects inferiorly from the diaphragmatic surface; this tissue 
generated a ventricular electrogram but communicated with the right atrium, not the right ventricular 
cavity above it. The dotted line indicates the site of the epicardial incision. In Diagram B, the right 
coronary fat pad was dissected away from the atrioventricular groove through an incision in the 
epicardium extending from the insertion of the inferior vena cava to the crux of the heart posteriorly. By 
sharp and blunt dissection under the eleva.ted fat pad the atrium was separated from the ventricle along 
this entire Rength, exposing the roof of the coronary sinus and posterior portion of the ventricular septum. 
A through-and-through incision was then made in the atrialized ventricle at the point of separation from 
the ventricular septum and coronary sinus to insure complete division of al.1 fibers between the atrium and 
ventricle. The epicardial and endocardial incisions were then closed. Diagrams C through F illustrates the 
modified Fontan technique. The pulmonary valve was normal in size; therefore it was incorporated into 
the repair. ‘The atria1 septal defect was closed with a Dacron patch. A 5 cm longitudinal incision was made 
in the right ventricular infundibulum. A 5- by 5-cm flap of right atria1 appendage was folded back and 
sutured to the right edge of the ventriculotomy to form the floor of the conduit (Diagrams C and 0). Then 
a 7-by-9 cm rectangle of pericardium was sutured to the edge of the atria1 flap, and to the left edge of the 
ventriculotomy to constitute the roof of the conduit (Diagrams E and F). Upon completion of the 
procedure, the patient was in sinus rhythm without anomalous atrioventricular conduction (Fig. 1, 
right-hand panel). 
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conduction was explained by finding a delay in intra-atrial 
conduction (PA interval 53 msec). Finally, the antegrade 
effective refractory period in the anomalous pathway of 
greater than 450 msec (sinus cycle length 740 msec) 
reduced the risk of the initiation of either ventricular 
tachycardia or ventricular fibrillation. 
The finding of the Ebstein-like defect at surgery (Fig. 
5,A) raises the question of the anatomy of the primary 
lesion-Ebstein’s anomaly or tricuspid atresia. The major 
classification of tricuspid atresia is dependent upon the 
associated lesions.’ More recently several authors have 
classified tricuspid atresia by the type of obstruction of 
the tricuspid valve.’ Our patient’s anatomy conforms to 
the Ebstein type of tricuspid atresia,’ whereas the patho- 
physiology, dependent upon the associated lesions, fits 
Edward’s type 1B.l Despite the “Ebstein-like” anatomy, 
severe hypoplasia of the right ventricle necessitated the 
Fontan operation. (Figs. 5,C to F). The surgical approach 
to the identification (Fig. 4) and division (Fig. 5,B) of the 
bypass tract was similar to previously described tech- 
niques in patients with posterior right-sided pathways 
with Ebstein’s anomaly.” The epicardial mapping proce- 
dure yielded precise localization of the accessory pathway 
(Fig. 4), allowing accurate and limited dissection (Fig. 
53). 
This experience underscores the importance of defining 
the mechanism of supraventricular tachycardias in 
patients with tricuspid atresia. Furthermore, patients with 
tachyarrhythmias and other forms of congenital heart 
disease should be evaluated electrophysiologically, since 
their tachyarrhythmia may depend upon anomalous 
atrioventricular pathways and therefore may be amenable 
to surgical treatment at the time of anatomic repair.+‘” 
We are grateful for the secretarial assistance of Ms. Ellen Clark 








Vald P: Tricuspid atresia. In Keith JP, Rowe RD, Vald P, 
editors: Heart Disease In Infancy and Childhood. New York, 
1978, MacMillan and Co, p 518: 
Dick M. Fvler DC. Nadas AS: Tricusuid atresia: Clinical 
course in 101 patients. Am J Cardiol36:327, 1975. 
Kyger ER, Reul GJ, Sandiford FM, Wukasch DC, Hallman 
GC, Cooley DA: Surgical palliation of tricuspid atresia. 
Circulation 52:685, 1975. 
Fontan F, Baudet E: Surgical repair of tricuspid atresia. 
Thorax 26:240, 1971. 
Gallagher JJ, Gilbert M, Sevenson RH, Seaiy WC, Kasell J, 
Wallace AG: Wolff-Parkinson-White syndrome, the prob- 
lem, evaluation, and surgical correction. Circulation 51:767, 
1975. 
Klein GJ, Bashore TM, Sellers TD, Pritcheet ELC, Smith 
WM, Gallagher JJ: Ventricular fibrillation in the Wolff- 
Parkinson-White syndrome. N Engl J Med 301:1080, 1979. 
Weinberg PM: Anatomy of tricuspid atresia and its rele- 
vance to current forms of surgical therapy. Ann Thorac 
Surg. 29:306, 1980. 
Sealy WC, Gallagher JJ, Pritchett ELC, Wallace AG: 
Surgical treatment of tachyarrhythmia in patients with 
both an Ebstein’s anomaly and a Kent bundle. J Thorac 
Cardiovasc Surg 75:847, 1978. 
Benson DW, Gallagher JJ, Spach MS, Barr RC, Edwards 
SB, Oldham HN, Kasell J: Accessory atrioventricular path- 
way in an infant: Prediction of location with body surface 
10. 
April 1981 
American Hearf Journal 
maps and ablation with cryosurgery. J Pediatr 96:41, 1980. 
Kugler JD, Gillette PC, Duff DF, Cobley DA, McNatnara 
DG: Elective mapping and surgical division of bundle of 
Kent with Ebstein’s anomaly who reqiuired tricuspid valve 
replacement. Am J Cardiol. 41:602, 1978. 
Romano-Ward prolonged QT synd 
with intermittent T wave alternans 
atrioventricular block 
Satyavan Sharma, K. G. Nair, and 
II. A. Gadekar, Bombay, India 
A 2X-year-old female presented with six episodes of 
generalized convulsions over a period of 6 months. There 
were no other cardiac symptoms and no history of sudden 
death in the family. Physical examination was normal. 
Electrocardiograms showed QT prolongation as a con- 
stant feature and intermittently T wave alternans was 
recorded (Fig. 1). On two occasions postconvulsions, 
electrocardiograms showed 2: 1 atrioventricular block (Fig. 
2). Although intravenous atropine caused disappearance 
of T wave alternans with decrease in QT interval, no 
response was induced by carotid sinus stimulation. All 
other relevant investigations performed including an 
audiogram were normal. The patient is no-w asymptomatic 
with institution of phenytoin and phenobarbital therapy. 
The QT interval continues to remain prolonged. 
In 1957 Jervell and Lange-Nielsen’ jointly reported the 
peculiar syndrome of QT prolongation with deafness. The 
syndrome without deafness has been termed the Romano- 
Ward syndrome. Syncopal episodes in these syndromes 
have been documented to be due to ventricular fibrilla- 
tion’ or less frequently to ventricular asystole.” In the 
Romano-Ward syndrome, the QT interval prolongation 
represents a stable feature, while T wave alternans is 
episodic and appears related to changes in activity of the 
sympathetic nervous system.’ In our patient T wave 
alternans was present at slower heart rates, but when the 
heart rate was increased by a vagolytic agent, T wave 
alternans disappeared. Similar findings have been 
reported by Lopez et al.” The presence of intermittent 
atrioventricular block is also an unusual feature in our 
case. This finding is consistent with the patient reported 
by Crawford et al.,” in whom atrioventricular nodal 
disease was progressive. 
No consistently effective therapy is available. Although 
propranolol is considered to be the most effective drug for 
preventing ventricular tachyarrhythmias, the agent is 
unsafe in the presence of atrioventricular nodal disease 
because of its action of depressing atrioventricular con- 
duction. Phenytoin (diphenylhydantoin) has been suc- 
cessfully employed, as in our patient, because of the 
agent’s inhibitory effect on central nervous system dis- 
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